$GTCH
GBT Technologies Inc. Stock $gtch

$gtch Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000173112223001540 Filed on August 17, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue		$131.4K	$345.0K
YoY Change		-61.91%	666.62%
Cost Of Revenue		$148.8K	$179.5K
YoY Change		-17.07%
Gross Profit		-$17.41K	$165.5K
YoY Change		-110.52%
Gross Profit Margin		-13.25%	47.98%
Selling, General & Admin	$127.7K	$190.6K	$926.3K
YoY Change	-49.99%	-79.42%	32.29%
% of Gross Profit			559.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$317.4K	$334.5K	$926.3K
YoY Change	-49.9%	-63.89%	32.29%
Operating Profit	-$317.4K	-$351.9K	-$760.8K
YoY Change	-39.95%	-53.75%
Interest Expense	$156.5K	$359.3K	-$2.737M
YoY Change	-40.24%	-113.13%	-210.19%
% of Operating Profit
Other Income/Expense, Net	$283.4K	-$9.564M	$56.83K
YoY Change	-87.67%	-16928.88%	-81.06%
Pretax Income	-$33.98K	-$9.916M	-$3.441M
YoY Change	-101.92%	188.15%	-87.28%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$72.56K	-$9.909M	-$3.441M
YoY Change	-104.1%	187.96%	-87.28%
Net Earnings / Revenue		-7540.02%	-997.49%
Basic Earnings Per Share	$0.00	$0.00	-$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$9.715K
COMMON SHARES
Basic Shares Outstanding	6.704B shares	2.930B shares	354.2M shares
Diluted Shares Outstanding	28.67B shares	28.49B shares	4.526B shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.10K	$56.57K	$161.3K
YoY Change	-70.13%	-64.92%	-46.39%
Cash & Equivalents	$592.00	$44.07K	$464.4K
Short-Term Investments	$38.51K	$12.51K	$87.16K
Other Short-Term Assets	$0.00	$452.00	$434.2K
YoY Change	-100.0%	-99.9%
Inventory		$12.86K	$17.05K
Prepaid Expenses
Receivables		$35.54K	$102.2K
Other Receivables		$197.2K	$0.00
Total Short-Term Assets	$239.9K	$354.6K	$714.7K
YoY Change	-72.15%	-50.38%	-52.38%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL ASSETS
Total Short-Term Assets	$239.9K	$354.6K	$714.7K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$239.9K	$354.6K	$714.7K
YoY Change	-72.15%	-50.38%	-76.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.144M	$1.029M	$1.526M
YoY Change	4.99%	-32.54%	74.78%
Accrued Expenses	$1.300M	$1.182M	$7.736M
YoY Change	96.81%	-84.72%	19.97%
Deferred Revenue	$0.00	$36.44K
YoY Change	-100.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.808M	$6.935M	$9.621M
YoY Change	-0.54%	-27.91%	161.42%
Total Short-Term Liabilities	$30.55M	$31.05M	$25.09M
YoY Change	33.31%	23.79%	0.31%
LONG-TERM LIABILITIES
Long-Term Debt	$312.2K	$310.8K	$352.0K
YoY Change	0.13%	-11.72%	-96.15%
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$312.2K	$310.7K	$352.0K
YoY Change	0.13%	-11.72%	-96.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.55M	$31.05M	$25.09M
Total Long-Term Liabilities	$312.2K	$310.7K	$352.0K
Total Liabilities	$30.86M	$31.36M	$25.44M
YoY Change	32.87%	23.3%	-25.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$314.8M	-$314.8M
YoY Change	4.14%
Common Stock	$69.04K	$55.51K
YoY Change	483.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$643.1K	$643.1K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	-$30.67M	-$31.05M	-$24.72M
YoY Change
Total Liabilities & Shareholders Equity	$239.9K	$354.6K	$714.7K
YoY Change	-72.15%	-50.38%	-76.18%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$72.56K	-$9.909M	-$3.441M
YoY Change	-104.1%	187.96%	-87.28%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$147.5K	-$104.6K	-$8.900K
YoY Change	50.39%	1074.83%	-98.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$150.0K
YoY Change		-100.0%
Cash From Investing Activities	$0.00	$0.00	-$150.0K
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$163.6K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-89.97K	89.57K	126.6K
YoY Change	141.98%	-29.24%	-68.85%
NET CHANGE
Cash From Operating Activities	147.5K	-104.6K	-8.900K
Cash From Investing Activities	0.000	0.000	-150.0K
Cash From Financing Activities	-89.97K	89.57K	126.6K
Net Change In Cash	57.53K	-14.99K	-32.32K
YoY Change	-5.53%	-53.62%	-61.11%
FREE CASH FLOW
Cash From Operating Activities	$147.5K	-$104.6K	-$8.900K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001471781
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2023Q2	us-gaap	Unearned Premiums UnearnedPremiums		usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q2	gtch	Revenues From Related Parties RevenuesFromRelatedParties		usd
CY2022Q2	gtch	Revenues From Related Parties RevenuesFromRelatedParties		usd
	gtch	Revenues From Related Parties RevenuesFromRelatedParties		usd
CY2022Q2	us-gaap	Other Expenses OtherExpenses		usd
	us-gaap	Other Expenses OtherExpenses		usd
	us-gaap	Other Expenses OtherExpenses		usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q2	gtch	Common Stock Issued For Jv Tokenize CommonStockIssuedForJvTokenize		usd
CY2022Q2	gtch	Equity Method Investment Meta EquityMethodInvestmentMeta		usd
	gtch	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
	gtch	Investment To Gtx InvestmentToGtx		usd
	gtch	Investment To Tghi InvestmentToTghi		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	gtch	Issuance Of Note Receivable IssuanceOfNoteReceivable		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	gtch	Share Issuance For Jv Metaverse ShareIssuanceForJvMetaverse		usd
	gtch	Share Issuance For Jv Tokenize ShareIssuanceForJvTokenize		usd
CY2022Q4	gtch	Convertible Notes Payable Longterm Portion ConvertibleNotesPayableLongtermPortion		usd
CY2023Q2	gtch	Unamortized Debt Discount At Convertible Note Payable UnamortizedDebtDiscountAtConvertibleNotePayable		usd
CY2022Q4	gtch	Unamortized Debt Discount At Convertible Note Payable UnamortizedDebtDiscountAtConvertibleNotePayable		usd
CY2023Q2	gtch	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	gtch	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	gtch	Debt Instruments Unamortized Discount Current DebtInstrumentsUnamortizedDiscountCurrent		usd
CY2023Q2	gtch	Debt Instruments Unamortized Discount Currents DebtInstrumentsUnamortizedDiscountCurrents		usd
CY2022Q4	gtch	Debt Instruments Unamortized Discount Currents DebtInstrumentsUnamortizedDiscountCurrents		usd
CY2023Q2	gtch	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	gtch	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54530
	dei	Entity Registrant Name EntityRegistrantName	GBT TECHNOLOGIES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0603137
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2450 Colorado Ave.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100E
	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Monica
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90404
	dei	City Area Code CityAreaCode	888
	dei	Local Phone Number LocalPhoneNumber	685-7336
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6703695062	shares
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44068	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106639	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35536	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25244	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	12860	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	11569	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	52000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12500	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	197216	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	198475	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	452	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	12506	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	16198	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	354638	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	370625	usd
CY2023Q2	us-gaap	Assets Assets	354638	usd
CY2022Q4	us-gaap	Assets Assets	370625	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5789679	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6240634	usd
CY2023Q2	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	us-gaap	Unearned Premiums UnearnedPremiums	48921	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	36444	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	41444	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5964806	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	6397727	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	708395	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	116605	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	122093	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	41137	usd
CY2023Q2	gtch	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2022Q4	gtch	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2023Q2	gtch	Due To Related Party Current DueToRelatedPartyCurrent	91332	usd
CY2022Q4	gtch	Due To Related Party Current DueToRelatedPartyCurrent	62003	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14109864	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1714143	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	31052670	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18892671	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	7415	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	303333	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	308863	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	310748	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	308863	usd
CY2023Q2	us-gaap	Liabilities Liabilities	31363418	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19201534	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1535593440	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33200198	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	55508	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	15356	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	21	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	21	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	643059	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	643059	usd
CY2023Q2	gtch	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2022Q4	gtch	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	291992310	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	288664858	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-314847007	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-299257917	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-31052395	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-18830909	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	43614	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-31008781	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-18830909	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	354638	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	370625	usd
CY2023Q2	gtch	Sales Sales	131419	usd
CY2022Q2	gtch	Sales Sales	344981	usd
	gtch	Sales Sales	349204	usd
	gtch	Sales Sales	569951	usd
	gtch	Revenues From Related Parties RevenuesFromRelatedParties	45000	usd
CY2023Q2	us-gaap	Revenues Revenues	131419	usd
CY2022Q2	us-gaap	Revenues Revenues	344981	usd
	us-gaap	Revenues Revenues	349204	usd
	us-gaap	Revenues Revenues	614951	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	148827	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	179471	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	324918	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	388458	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-17408	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	165510	usd
	us-gaap	Gross Profit GrossProfit	24286	usd
	us-gaap	Gross Profit GrossProfit	226493	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	133533	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	241869	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	282934	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	371252	usd
CY2023Q2	us-gaap	Marketing Expense MarketingExpense	57099	usd
CY2022Q2	us-gaap	Marketing Expense MarketingExpense	92168	usd
	us-gaap	Marketing Expense MarketingExpense	111997	usd
	us-gaap	Marketing Expense MarketingExpense	433300	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	143869	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	592305	usd
	us-gaap	Professional Fees ProfessionalFees	437799	usd
	us-gaap	Professional Fees ProfessionalFees	1128192	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	334501	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	926342	usd
	us-gaap	Operating Expenses OperatingExpenses	832730	usd
	us-gaap	Operating Expenses OperatingExpenses	1932744	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-351909	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-760832	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-808444	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1706251	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	120797	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	239394	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	268423	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	307879	usd
CY2023Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-9104239	usd
CY2022Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-2088840	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-13028486	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	3150739	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	359290	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	233900	usd
	us-gaap	Interest Expense InterestExpense	1954940	usd
	us-gaap	Interest Expense InterestExpense	469393	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	6031	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	315297	usd
CY2022Q2	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	50000	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	50000	usd
CY2023Q2	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	-4855	usd
CY2022Q2	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	175000	usd
	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	3692	usd
	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	240000	usd
CY2023Q2	gtch	Related Party Transaction Other Revenue From Transactions With Related Party RelatedPartyTransactionOtherRevenueFromTransactionsWithRelatedParty	9586	usd
CY2022Q2	gtch	Related Party Transaction Other Revenue From Transactions With Related Party RelatedPartyTransactionOtherRevenueFromTransactionsWithRelatedParty	6828	usd
	gtch	Related Party Transaction Other Revenue From Transactions With Related Party RelatedPartyTransactionOtherRevenueFromTransactionsWithRelatedParty	203212	usd
	gtch	Related Party Transaction Other Revenue From Transactions With Related Party RelatedPartyTransactionOtherRevenueFromTransactionsWithRelatedParty	7886	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9563854	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2680306	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14737032	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2191353	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9915763	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3441138	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15545476	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	485102	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9915763	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3441138	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-15545476	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	485102	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-9915763	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3441138	usd
	us-gaap	Profit Loss ProfitLoss	-15545476	usd
	us-gaap	Profit Loss ProfitLoss	485102	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6741	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43614	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-9909022	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3441138	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15589090	usd
	us-gaap	Net Income Loss NetIncomeLoss	485102	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5161471785	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	354196118	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3392096025	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	354381392	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28485320260	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4526076373	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26715944500	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4526261647	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-18830909	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	403548	usd
CY2023Q1	gtch	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	316223	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5629713	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-23660851	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	881372	usd
CY2023Q2	gtch	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	1686461	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9915763	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-31008781	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28761981	usd
CY2022Q1	gtch	Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest	35000	usd
CY2022Q1	gtch	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	49504	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	68308	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3926239	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-24682930	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1666860	usd
CY2022Q2	gtch	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	1571238	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	163559	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3441137	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-24722410	usd
	us-gaap	Profit Loss ProfitLoss	-15545476	usd
	us-gaap	Profit Loss ProfitLoss	485102	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	268423	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	307879	usd
	gtch	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	13028486	usd
	gtch	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-3150739	usd
	gtch	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts	1528816	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	80000	usd
	gtch	Change In Fair Value Of Marketable Security ChangeInFairValueOfMarketableSecurity	3692	usd
	gtch	Change In Fair Value Of Marketable Security ChangeInFairValueOfMarketableSecurity	240000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	315297	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10292	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1259	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3747836	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	39500	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	452	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1291	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	60925	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-48921	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-225	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3556	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	838357	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1330044	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-217196	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	235328	usd
	gtch	Investment To Gtx InvestmentToGtx	150000	usd
	gtch	Investment To Tghi InvestmentToTghi	125000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-275000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	92150	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	200000	usd
	gtch	Issuance Of Note Receivable IssuanceOfNoteReceivable	100000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	231865	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	549564	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	558379	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	59004	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	578893	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	575516	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	92150	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	154625	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	349002	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-62571	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	309330	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106639	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155106	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44068	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	464436	usd
	us-gaap	Interest Paid InterestPaid	2898	usd
	gtch	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	63379	usd
	gtch	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	191741	usd
	gtch	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	2002684	usd
	gtch	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	1620742	usd
	gtch	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	1284920	usd
	gtch	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	1701864	usd
	gtch	Share Issuance For Jv Metaverse ShareIssuanceForJvMetaverse	5000	usd
	gtch	Share Issuance For Jv Tokenize ShareIssuanceForJvTokenize	1500	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 50
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-500
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-314847007	usd
	gtch	Working Capital Deficit WorkingCapitalDeficit	30698032	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zJh9eeFjsnTf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86C_zDB1aSUKt1P9">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q2	gtch	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	14109864	usd
CY2023Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	0	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_849_eus-gaap--DerivativesReportingOfDerivativeActivity_zUsx5diY1nQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_866_znc0wkad3IQg">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of June 30, 2023 and December 31, 2022, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q4	gtch	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	1714143	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	48921	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	36444	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	41444	usd
CY2022Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	200000	usd
CY2023Q2	gtch	Number Of Shares Received NumberOfSharesReceived	26000000	shares
CY2023Q2	us-gaap	Investments Investments	0	usd
CY2022Q4	us-gaap	Investments Investments	0	usd
	gtch	Convertible Note Payable Description ConvertibleNotePayableDescription	IGOR 1 converted $639,710 of the convertible note into 1,926,000,000 shares of the Company’s common stock.
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	59408	usd
CY2023Q1	gtch	Original Issue Discounts OriginalIssueDiscounts	6258	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	53150	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	79744214039	shares
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3949223831	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	79744350509	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3949360301	shares
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.01
CY2023Q2	us-gaap	Shares Issued SharesIssued	2000000	shares
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1029063	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1530762	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1182390	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1513261	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3578226	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3196611	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5789679	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6240634	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	48921	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	6010926	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	6586788	usd
CY2023Q2	gtch	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-89285	usd
CY2022Q4	gtch	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-189060	usd
CY2023Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	5972221	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	6397727	usd
CY2023Q2	gtch	Less Current Portion LessCurrentPortion	-5964806	usd
CY2022Q4	gtch	Less Current Portion LessCurrentPortion	-6397727	usd
CY2023Q2	gtch	Convertible Notes Payable Longterm Portion ConvertibleNotesPayableLongtermPortion	7415	usd
CY2022	gtch	Charge Related To Modification Of Debt ChargeRelatedToModificationOfDebt	13777480	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-06-01
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	7128	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	6654	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-06-01
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	47208	usd
CY2023Q2	gtch	Original Issue Discounts OriginalIssueDiscounts	5058	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	42150	usd
CY2023Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-04-24
CY2023Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5664	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	5287	usd
CY2023Q2	gtch	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	708395	usd
CY2022Q4	gtch	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	116605	usd
CY2023Q2	gtch	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	708395	usd
CY2022Q4	gtch	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	116605	usd
CY2023Q2	gtch	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-708395	usd
CY2022Q4	gtch	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-116605	usd
CY2023Q2	gtch	Total Notes Payables TotalNotesPayables	436655	usd
CY2022Q4	gtch	Total Notes Payables TotalNotesPayables	350000	usd
CY2023Q2	gtch	Debt Instruments Unamortized Discount Current DebtInstrumentsUnamortizedDiscountCurrent	-11229	usd
CY2023Q2	gtch	Note Payables NotePayables	425426	usd
CY2022Q4	gtch	Note Payables NotePayables	350000	usd
CY2023Q2	gtch	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	122093	usd
CY2022Q4	gtch	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	-41137	usd
CY2023Q2	gtch	Long Term Note Payables LongTermNotePayables	303333	usd
CY2022Q4	gtch	Long Term Note Payables LongTermNotePayables	308863	usd
	gtch	Schedule Of Note Payable Related Parties Table Textblock ScheduleOfNotePayableRelatedPartiesTableTextblock	<table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_z7tA1a8iXdL1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zlRGo93iZiTc" style="display: none">Schedule of notes payable related parties</span></td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="3" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30,</span></td> <td><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="3" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Alpha Eda note payable</span></td> <td style="width: 8%; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td id="xdx_987_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20230630__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zs78rJOZzKxb" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable"><span style="font: 10pt Times New Roman, Times, Serif">140,000</span></td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="width: 8%; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20221231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable"><span style="font: 10pt Times New Roman, Times, Serif">140,000</span></td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total notes payable, related party</span></td> <td><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_981_ecustom--TotalNotesPayableRelatedParties_iI_pp0p0_c20230630_zTqiETHU95za" style="text-align: right" title="Total notes payable"><span style="font: 10pt Times New Roman, Times, Serif">140,000</span></td> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_98A_ecustom--TotalNotesPayableRelatedParties_c20221231_pp0p0" style="text-align: right" title="Total notes payable"><span style="font: 10pt Times New Roman, Times, Serif">140,000</span></td> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Unamortized debt discount</span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_98C_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_pdp0_c20230630_zi0cLm4R2RQf" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1450">—</span></span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_98E_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_c20221231_pdp0" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1452">—</span></span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Notes payable, net, related party</span></td> <td><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_98F_ecustom--NotesPayableRelatedParties_iI_pp0p0_c20230630_zxoacfERY5k2" style="text-align: right" title="Notes payable"><span style="font: 10pt Times New Roman, Times, Serif">140,000</span></td> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_98C_ecustom--NotesPayableRelatedParties_c20221231_pp0p0" style="text-align: right" title="Notes payable"><span style="font: 10pt Times New Roman, Times, Serif">140,000</span></td> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Less current portion</span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_981_ecustom--CurrentPortionOfNotePayableRelatedParties_iI_pp0p0_c20230630_zeX9mz5JIW3d" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion"><span style="font: 10pt Times New Roman, Times, Serif">(140,000</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_981_ecustom--CurrentPortionOfNotePayableRelatedParties_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion"><span style="font: 10pt Times New Roman, Times, Serif">(140,000</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Notes payable, net, related party, long-term portion</span></td> <td style="padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td id="xdx_989_ecustom--NotesPayableNetRelatedPartyLongtermPortion_iI_pdp0_c20230630_ziPFb7D7sQ8k" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1462">—</span></span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td id="xdx_983_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20221231_pdp0" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font: 10pt Times New Roman, Times, Serif"></span><span style="-sec-ix-hidden: xdx2ixbrl1464">—</span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table>
CY2023Q2	gtch	Total Notes Payable Related Parties TotalNotesPayableRelatedParties	140000	usd
CY2022Q4	gtch	Total Notes Payable Related Parties TotalNotesPayableRelatedParties	140000	usd
CY2023Q2	gtch	Notes Payable Related Parties NotesPayableRelatedParties	140000	usd
CY2022Q4	gtch	Notes Payable Related Parties NotesPayableRelatedParties	140000	usd
CY2023Q2	gtch	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2022Q4	gtch	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2023Q2	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.00042
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.001
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1714142	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	1369920	usd
	gtch	Fair Value Of Beneficial Conversion Feature Of Debt Converted FairValueOfBeneficialConversionFeatureOfDebtConverted	2002684	usd
	gtch	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos	13028486	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	14109864	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	3915160446	shares
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1232709	usd
	gtch	Debt Conversion Converted Instrument Accrued Interest DebtConversionConvertedInstrumentAccruedInterest	52211	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	70770	shares
	gtch	Weighted Average Exercise Price Warrants Outstanding Beginning WeightedAverageExercisePriceWarrantsOutstandingBeginning	205.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	60100	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10670	shares
	gtch	Weighted Average Exercise Price Warrants Outstanding End WeightedAverageExercisePriceWarrantsOutstandingEnd	729.90
	gtch	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1	P0Y7D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	10670	shares
	gtch	Weighted Average Exercise Price Warrants Exercisable At End WeightedAverageExercisePriceWarrantsExercisableAtEnd	729.90
	gtch	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms	P0Y7D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10670	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	10670	shares
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_80C_eus-gaap--LossContingencyDisclosures_zMk5IMyDLWT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 15 - <span id="xdx_825_zqnIygpKqsf8">Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>GBT Technologies, S.A.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $<span id="xdx_907_eus-gaap--Revenues_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zpUQaAJuJj2h" title="Revenues">300,000</span> which is nonrefundable. The Company recognized the $300,000 as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $<span id="xdx_905_ecustom--PaymentForExpenses_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zkL6lRaEXvfl" title="Payment for expenses">5,000,000</span>. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $<span id="xdx_90A_eus-gaap--DeferredRevenue_iI_pp0p0_c20230630__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zkHomrE5uBT6" title="Unearned revenue">200,000</span> to the Company, which the parties have agreed will be applied toward the $5,000,000 fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stock Loan Receivable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190107__20190108_zghQWnb80mCc" title="Restricted shares">4,006</span> restricted shares of its common stock valued at $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20190107__20190108_zsooOEprjTZf" title="Value of restricted shares">7,610,147</span> (based on the closing price on the grant date) for three years for an annual payment of $<span id="xdx_900_ecustom--AnnualPayment_iI_c20190108_zf1hziwtlqu7" title="Annual payment">375,000</span> paid in quarterly installments of $<span id="xdx_90B_eus-gaap--DebtInstrumentPeriodicPayment_c20190107__20190108_zxjsP8jtv5vf" title="Instalment paid">93,750</span>. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $<span id="xdx_905_ecustom--DecreaseInCapital_c20190107__20190108_z0ShDIxoeMRh" title="Decrease in capital">5,000,000</span>, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20230101__20230630_zxajeMtD9duf" title="Restricted shares">4,006</span> restricted shares have not yet been returned to the Company as of June 30, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Investment in Surge</i> Holdings<i>, Inc.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 30, 2019, GBT Technologies Inc. (the “Company”) entered into an Asset Purchase Agreement (“APA”) with Surge Holdings, Inc., a Nevada corporation (“SURG”) pursuant to which the Company agreed to sell and assign to SURG, all the assets and certain specified liabilities, of its ECS Prepaid, Electronic Check Services and the Central State Legal Services businesses for $<span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20190929__20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zVQkzyuyXbD1" title="Business consideration values">5,000,000</span> to be paid through the issuance of <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20190929__20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zle3gIdhtnP5" title="Sale of common stock">3,333,333</span> shares of SURG’s common stock (the “SURG Common Stock”) and a convertible promissory note in favor of the Company in the principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20190929__20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_pp0p0" title="Payment of principal">4,000,000</span> (the “SURG Note”), convertible into SURG’s shares of common stock. On January 7, 2022, the Company received payments from Surgepays Inc. (formerly known as Surge Holdings, Inc.) in total of $<span id="xdx_901_ecustom--SettlementPursuantsAmount_pp0p0_c20220106__20220107__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zcpfPmHmgqO3" title="Settlement pursuant amount">3,750,000</span> pursuant to the terms of the Settlement Agreement dated December 22, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 23, 2020, SURG entered into an Exchange Agreement (the “AltCorp Exchange Agreement”) with AltCorp Trading LLC (“AltCorp”) with such AltCorp Exchange Agreement being consented and agreed to by the Company, the parent of AltCorp. At the expiration of the lock-up period, in the event the VWAP for the SURG Common Stock was, during the preceding twenty-day trading period, less than $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20200623__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AltCorpExchangeAgreementMember_zMm4x5yV8IY" title="Price per share">0.50</span> per share, AltCorp retained the right to reserve additional shares of SURG Common Stock equal to the True-Up Value as defined in the AltCorp Exchange Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 8, 2020, SURG filed a lawsuit against its transfer agent from transferring millions of SURG stock that is currently in possession by the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $<span id="xdx_90B_eus-gaap--DebtCurrent_iI_pp0p0_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zd2Nod0Ji18a" title="Debt">3,300,000</span> (the “Debt”) to be paid in 33 monthly payments of $<span id="xdx_906_eus-gaap--DebtCurrent_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0" title="Debt">100,000</span> payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the 10 trading days immediately preceding the issuance. SURG paid $<span id="xdx_904_eus-gaap--Cash_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Cash">400,000</span> in cash and $<span id="xdx_90E_eus-gaap--Cash_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0" title="Cash">800,000</span> by shares. The SURG common stock issued to Altcorp have been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $<span id="xdx_902_eus-gaap--RepaymentsOfDebt_pp0p0_c20220106__20220107__dei--LegalEntityAxis__custom--SurgeHoldingsIncMember_zOi6Ih601bd8" title="Repayment of debt">4,200,000</span> to the Company’s trust account on or prior to January 7, 2022. <span id="xdx_903_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20230101__20230630__dei--LegalEntityAxis__custom--SurgeHoldingsIncMember_zxloN2iRi44a" title="Related party, description">This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2021, the Company recorded an outstanding payable to Stanley amounted $1,862,928 recorded under accrued expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsequently, SURG was a party to two lawsuits in state District Court, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were ultimately disputes relating to the total consideration SURG was to pay the Company under the APA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Office–) - in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The Final Settlement Agreement, among other resolutions, essentially provides the following: i) From the total consideration of the Final Settlement Agreement, the amount of $<span id="xdx_90E_eus-gaap--EscrowDeposit_iI_pp0p0_c20230630__dei--LegalEntityAxis__custom--SurgeHoldingsIncMember_z5OW2dXB2j62" title="Escrow deposit amount">375,000</span> (“Escrow Amount”) will be deposited by SURG in escrow. SURG has acquired the Company’s rights to a certain Master Distribution and Service Agreement (“MDA”). Under certain circumstances, if the result of the Company’s lawsuit against a third party (the “GBT Lawsuit”) is a monetary judgment without the assignment or legal decree of ownership of the MDA, the Company shall be entitled to receive the Escrow Amount and shall assign to SURG the first $<span id="xdx_900_ecustom--EscrowAmountReceived_pp0p0_c20230101__20230630_zxu8SGcIsFZ1" title="Escrow amount received">1,000,000</span> the Company recovers from the defendants in the GBT Lawsuit. In the event that the Company does not prevail in the GBT Lawsuit then it shall be entitled to release of the Escrow Amount but shall be responsible for any fees and costs obligation sought by the defendants in the GBT Lawsuit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(ii) <span id="xdx_904_ecustom--FinalSettlementAgreementDescription_c20230101__20230630_zshmrjE61WVh" title="Final settlement agreement, description">SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(iii) Potential payments to third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Final Settlement Agreement replaces all prior agreements between the parties. In addition, within three (3) trading days of the last payment of $<span id="xdx_906_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_dm_c20230101__20230630_zyobFEVOIFld" title="Related party payment">4.2</span> million payment to Stanley being made, the parties shall make filings with the state District Court in Clark County, Nevada to dismiss both lawsuits, including, regarding the lawsuit filed by AltCorp Trading, LLC, the dismissal of the lawsuit as to VStock Transfer, LLC. The parties agreed to a full mutual release of any disputes or claims between the parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The final settlement of $<span id="xdx_906_ecustom--SettlementAmount_iI_pp0p0_c20220131_zdIbRtAPvRK1" title="Settlement amount">3,750,000</span> was received by the Company in January 2022 and paid out $<span id="xdx_909_eus-gaap--ProceedsFromShortTermDebt_pp0p0_c20220101__20221231_zHmrcIbZBI72" title="Payments for debt">3,750,000</span> to the third parties before December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As the Company committed to assign certain revenue share agreement to SURG as part of the Company’s settlement with RWJ Agreement, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to the SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the aforereferenced agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2023 and as of December, 31 2022 there is no balances with regard to this transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Assignment of lease agreement</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $<span id="xdx_90B_eus-gaap--LeaseAndRentalExpense_c20220516__20220517_zcWm0xtknRai" title="Payment of base rent">4,100</span> per month and share of common area operating expense shall equal $<span id="xdx_903_eus-gaap--OperatingExpenses_c20220516__20220517_zFzdXBfpevY9" title="Operating expense">200</span> per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Metaverse Agreements</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 10, 2022, the Company, entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 5.2pt 0 0; text-align: justify; background-color: white">Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute <span id="xdx_905_eus-gaap--SharesIssued_iI_c20230630__dei--LegalEntityAxis__custom--GBTMember_z1JMxuuyWKx2" title="Share issued">500,000,000</span> shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its 50% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 5.2pt 0 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $25,000 per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The closing of the Metaverse Agreement occurred on June 13, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $5,000 to the Company as settlement payment and surrender their shares in Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 1, 2023, the Company engaged AlKhatib Consulting Group to provide exclusive representation services in connect with managing market partners, effective on February 1, 2012 for 24 consecutive months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Assets Sale - TREN</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned <span id="xdx_907_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_dp_c20230403__srt--OwnershipAxis__custom--GBTechnologiesIncMember_zZyomYiiiljc" title="Ownership percentage">50</span>% by the Company, entered into an agreement to sell certain assets relating to a proprietary system and method named Avant-Ai to TREN. Avant-Ai is a text-generation, deep learning self-training model. In exchange for the assets, TREN is required to issue <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230402__20230403__dei--LegalEntityAxis__custom--GBTechnologiesIncMember_zKWDi4CYc7a4" title="Number of shares sold">26,000,000</span> common shares (“Shares”) to Seller. The Shares will be restricted under Rule 144 of the Securities Act of 1933, as amended, and Seller agreed to a lock-up period of nine months following closing. If TREN is unable to up-list to Nasdaq either through a business combination or otherwise within nine months of the closing, Seller may request that all transactions contemplated by the agreement be unwound.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 18, 2023, TREN changed its name to Avant Technologies, Inc. and its ticker symbol on OTC Markets was changed to AVAI.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Potential IP’s Sale</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: black">On April 17, 2023, the Company, Bannix Acquisition Corp. (“Bannix”) and EVIE Autonomous Ltd. (“EVIE”) pursuant to which Bannix agreed to acquire EVIE. In addition, Bannix </span>agreed to acquire from the Company the Apollo System which is intellectual property covered by patent application (publication number 2022/0405966) filed with the US Patent and Trademark Office. This patent application describes a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and moving objects. The Apollo system is based on radio waves and can detect an entity’s moving and stationary positions, enabling imaging technology to show these movements and positions on a screen in real time. This includes an AI technology that controls the radio waves transmission and analyzes the reflections. The goal is to integrate the Apollo System as an efficient driver monitoring system, detecting impaired or distracted drivers, providing audible and visual alerts. Consummation of the above transactions are subject to the execution of a mutually satisfactory definitive agreement by the Company, Bannix and EVIE (the “Definitive Agreement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Service Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 24, 2023 the Company entered into service agreement with Pacific Capital Markets LLC , where <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230223__20230224__dei--LegalEntityAxis__custom--PacificCaptitalMarketsLLCMember_zQK2SYMyV52d" title="Number of shares issued, shares">100,000,000</span> Shares issued to it for certain for service agreement between Pacific Captital Markets LLC. and the Company. The value of the shares of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230223__20230224__dei--LegalEntityAxis__custom--PacificCaptitalMarketsLLCMember_zi6qV3xmWFbe" title="Number of shares issued, value">80,000</span> was determined based on the FV of the Company’s common stock. Pacific Capital Markets never granted the contracted services, and been notified accordingly by the Company. Specifically, GBT, as a Nevada Corporation, ”may authorize shares to be issued for consideration consisting of any tangible or intangible property or benefit to the corporation, including, but not limited to, cash, promissory notes, services performed, [or] contracts for services to be performed...” NRS 78.211(1). As such on or Friday, July 14, 2023 the Company’s Board adopted a resolution to immediately cancel the transfer of Shares in its entirety, and commence action on it.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2019Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4006	shares
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	7610147	usd
CY2019Q1	gtch	Annual Payment AnnualPayment	375000	usd
CY2019Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	93750	usd
CY2019Q1	gtch	Decrease In Capital DecreaseInCapital	5000000	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4006	shares
	gtch	Escrow Amount Received EscrowAmountReceived	1000000	usd
	gtch	Final Settlement Agreement Description FinalSettlementAgreementDescription	SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022.
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	4200000	usd
CY2022Q1	gtch	Settlement Amount SettlementAmount	3750000	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	3750000	usd
CY2022Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4100	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	200	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001

Files In Submission

Name	View Source	Status
0001731122-23-001540-index-headers.html	Edgar Link	pending
0001731122-23-001540-index.html	Edgar Link	pending
0001731122-23-001540.txt	Edgar Link	pending
0001731122-23-001540-xbrl.zip	Edgar Link	pending
e4947_10q.htm	Edgar Link	pending
e4947_ex31-1.htm	Edgar Link	pending
e4947_ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gtch-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
gtch-20230630_cal.xml	Edgar Link	unprocessable
gtch-20230630_def.xml	Edgar Link	unprocessable
gtch-20230630_lab.xml	Edgar Link	unprocessable
gtch-20230630_pre.xml	Edgar Link	unprocessable
e4947_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTCH
GBT Technologies Inc. Stock $gtch

2023 Q3 Form 10-Q Financial Statement

#000173112223001540 Filed on August 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH GBT Technologies Inc. Stock $gtch

2023 Q3 Form 10-Q Financial Statement

#000173112223001540 Filed on August 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH
GBT Technologies Inc. Stock $gtch